Participant flow

Autologous Transplant for Multiple Myeloma · Source last updated 2021-11-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receiving peripheral blood stem cell mobilization, chemotherapy (cyclophosphamide + Mesna, growth factor (Granulocyte-colony stimulating factor) and autologous Peripheral Blood Stem Cell transplant with high dose melphalan (200 mg/m\^2). Post-transplant maintenance therapy is then prescribed if appropriate.

   id

   FG000

   title

   Chemotherapy and Transplant Treatment

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         363

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         363

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice